INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 16, 2004 |
Director
Trans History: 742
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 245,682 |
| Jun 23, 2004 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 245,682 | -- | 245,682 |
| Apr 03, 2009 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 14,976 | -- | 246,355 |
| Jun 17, 2004 |
Director
Trans History: 742
|
Director | Form 4 | Other acquisition or disposition (describe transaction) | 189,345 | -- | 246,533 |
| Dec 13, 2013 |
Director, Pres Regeneron Labs
Trans History: 617
|
Director, Pres Regeneron Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 150,000 | -- | 246,736 |
| Dec 16, 2011 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 248,079 | -- | 248,079 |
| Aug 13, 2014 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 8,028 | $340.01 | 248,540 |
| Feb 19, 2019 |
Director, President and CSO
Trans History: 617
|
Director, President and CSO | Form 4 | Bona fide gift | 150,722 | -- | 249,278 |
| Dec 13, 2023 |
Director, Bd. Co-Chair, President & CEO
Trans History: 404
|
Director, Bd. Co-Chair, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 250,000 |
| May 17, 2023 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 250,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.